A comprehensive view of Genetically Modified Organisms (GMO) / Bioengineered Foods. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Kraig Biocraft Laboratories completes rearing of first generation of its new BAM-1 parental strains as part of its spring production trial; Kraig Labs successfully produced recombinant cocoons at rates that exceeded trial expectations, control parameters
Published:
April 22, 2024
by GlobeNewswire
|
Kraig Biocraft Laboratories announces that spring production trials for the new BAM-1 hybrid have begun and are on track to meet company's expectations, timeline; BAM-1 is Kraig Labs' newest, most robust recombinant spider silk production silkworm hybrid
Published:
April 15, 2024
by Kraig Biocraft Laboratories Inc.
|
Kraig Biocraft Labs CEO 'encouraged' by RPI's method of creating spider silk protein from waste plastics; Kraig's recombinant spider silk production model is different, as RPI method uses new strain of bacteria to depolymerize PE into recombinant proteins
Published:
March 28, 2024
by Kraig Biocraft Laboratories Inc.
|
Kraig Biocraft Laboratories' management will travel to Vietnam to oversee launch of spring production trials, lay groundwork for planned commercial expansion; BAM-1 production trial is next step in commercial-scale production of recombinant spider silk
Published:
March 12, 2024
by GlobeNewswire
|
FuturaGene's genetically modified eucalyptus with triple characteristics gets global approval from National Technical Biosafety Commission; approval marks first of its kind, promising more crop productivity, herbicide tolerance and resistance to insects
Published:
March 12, 2024
by CE Noticias Financieras (Latin America)
|
Ask us about our Health Care Sector market view